United Therapeutics | UTHR - Stock


United Therapeutics reported $201.9M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Amarin USD 158.85M 5.22M Sep/2026
Ardelyx USD 157.56M 18.57M Sep/2026
Baxter International USD 2.3B 41M Sep/2026
Bayer EUR 11.97B 43M Jun/2026
BioCryst Pharmaceuticals USD 13.74M 7.68M Sep/2026
Biogen USD 2.22B 159.9M Sep/2026
BioMarin Pharmaceutical USD 1.8B 13.54M Sep/2026
Emergent BioSolutions USD 328.9M 25.2M Dec/2023
Gilead Sciences USD 1.9B 57M Sep/2026
GlaxoSmithKline GBP 6.28B 125M Jun/2026
Halozyme Therapeutics USD 132.61M 4.52M Sep/2026
Insmed USD 163.95M 21.56M Sep/2026
Ionis Pharmaceuticals USD 28.58M 22.26M Sep/2026
J&J USD 15.38B 233M Sep/2026
Lexicon Pharmaceuticals USD 276K 5K Mar/2026
Moderna USD 313M 33M Sep/2026
Omeros USD 712K 266K Sep/2021
Pfizer USD 10.02B 77M Sep/2026
PTC Therapeutics USD 109.33M 17.98M Sep/2026
Regeneron Pharmaceuticals USD 2.89B 189.7M Sep/2026
Sarepta Therapeutics USD 876.12M 28.15M Sep/2026
Teva Pharmaceutical Industries USD 3.17B 48M Sep/2026
United Therapeutics USD 201.9M 8.1M Sep/2026
Vertex Pharmaceuticals USD 2.25B 480.2M Sep/2026